Skip to content

Clinical trials

Withdrawn Phase 3 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20132
20141
20171
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AtriCure, Inc.1
Axel Brandes1
Elpen Pharmaceutical Co. Inc.1
McMaster University1
Newmarket Electrophysiology Research Group Inc1
Population Health Research Institute1
Regional Hospital of Scranton1
University of Surrey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation8
Arrhythmias, Cardiac2
Stroke2
Cardiovascular Diseases1
Coronary Artery Disease1
Heart Diseases1
Heart Valve Diseases1
Hemorrhage1
Inflammation1
Myocardial Ischemia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.